Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0,0050
0,00%
(0,00) 1D
28 ຕ.ລ., 13 ໂມງ 31 ນາທີ 29 ວິນາທີ GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
286,61 ພັນ
Avg. vol.
773,00
Volume
0,00
52-wk high
CA$0,01
52-wk low
CA$0,00
EPS
CA$-0,00
Beta
14,27
Shares outstanding
57,07 ລ້ານ
Mkt. cap
286,61 ພັນ
Avg. vol.
773,00
Volume
0,00
52-wk high
CA$0,01
52-wk low
CA$0,00
EPS
CA$-0,00
Beta
14,27
Shares outstanding
57,07 ລ້ານ
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
Headquartersແວນຄູເວີ, ບຣິທິຊ ໂຄລຳເບຍ, ແຄນາດາ
SectorHealth Care
IndustryBiotechnology
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,77 ພັນ
2,06 ພັນ
2,95 ພັນ
1,58 ພັນ
Operating expense
34,77 ພັນ
2,06 ພັນ
2,95 ພັນ
1,58 ພັນ
Total operating expenses
34,77 ພັນ
2,06 ພັນ
2,95 ພັນ
1,58 ພັນ
Operating income
-34,77 ພັນ
-2,06 ພັນ
-2,95 ພັນ
-1,58 ພັນ
Other non operating income
-2,27 ພັນ
-1,16 ພັນ
-10,54 ພັນ
-1,91 ພັນ
EBT including unusual items
-39,64 ພັນ
-5,83 ພັນ
-16,55 ພັນ
-6,82 ພັນ
EBT excluding unusual items
-39,64 ພັນ
-5,83 ພັນ
-16,55 ພັນ
-6,82 ພັນ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39,64 ພັນ
-5,83 ພັນ
-16,55 ພັນ
-6,82 ພັນ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,61 ພັນ
-2,61 ພັນ
-3,06 ພັນ
-3,33 ພັນ
Net interest expenses
-2,61 ພັນ
-2,61 ພັນ
-3,06 ພັນ
-3,33 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 ພັນ
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google